The company also licenses its novel drug delivery technology, ENHANZE, for subcutaneous (SC) administration of drugs. HALO is a #3 (Hold) on the Zacks Rank, with a VGM Score of A. Momentum investors ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback